http://archive.fast-edgar.com/20261002/AQZ9822CJW22Q2Z2222L22ZEACF8Z22IB282
Filed on: October 2, 2026
Terms supplement to the prospectus dated April 17, 2026, the prospectus supplement dated April 17, 2026, the product supplement no. 3-I dated April 17, 2026, the underlying supplement no. 5-I dated April 17, 2026 Registration Statement Nos. 333-293684 and 333-293684-01 Dated October 2, 2026 Rule 424(b)(3) North America Structured Investments 5yrNC1yr MQUSTVA Auto Callable Contingent... (continue reading...)
Terms supplement to the prospectus dated April 17, 2026, the prospectus supplement dated April 17, 2026, the product supplement no. 3-I dated April 17, 2026, the underlying supplement no. 5-I dated April 17, 2026 Registration Statement Nos. 333-293684 and 333-293684-01 Dated October 2, 2026 Rule 424(b)(3) North America Structured Investments 5yrNC6m MQUSGVA Auto Callable Contingent... (continue reading...)
Terms supplement to the prospectus dated April 17, 2026, the prospectus supplement dated April 17, 2026, the product supplement no. 3-I dated April 17, 2026, the underlying supplement no. 5-I dated April 17, 2026 Registration Statement Nos. 333-293684 and 333-293684-01 Dated October 2, 2026 Rule 424(b)(3) North America Structured Investments 5yrNC6m MQUSTVA Auto Callable Contingent... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 8-K Century Therapeutics, For: Oct 02
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form D/A PMF Central Florida IV
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form D/A Anabranch Offshore Fund,
-
Form D/A Anabranch Fund, LP
-
Form 10-Q TAYLOR DEVICES, INC. For: Aug 31
-
Form 4 T Stamp Inc For: Sep 30 Filed by: McClintock William
-
Form 6-K Baozun Inc. For: Oct 02
-
Form 8-K HYPERION DEFI, INC. For: Sep 28
-
Form 8-K Surrozen, Inc./DE For: Oct 02
-
Form 4 T Stamp Inc For: Sep 30 Filed by: Potts Charles Edward
-
Form 8-K Celcuity Inc. For: Oct 01
-
Form 8-K Bally's Corp For: Oct 01
-
Form 6-K AC Immune SA For: Oct 02
-
Form 6-K PHAOS TECHNOLOGY HOLDING For: Sep 30
-
Form 8-K Thunder Bridge Capital For: Oct 02
-
Form 8-K/A OpenWorld, Inc. For: Sep 29
-
Form 4 Compass Therapeutics, For: Oct 01 Filed by: Lerner Neil
-
Form 8-K CNS Pharmaceuticals, For: Sep 30
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Wamp Zach Paul
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Bostick Thomas
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Grumski Joseph Timothy
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Shelton Larry
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: REEDER JOE
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: Duggan Kerry C
-
Form 4 PERMA FIX ENVIRONMENTAL For: Oct 01 Filed by: ZWECKER MARK A
-
Form 4 Uxin Ltd For: Oct 01 Filed by: Dai Kun
-
Form 8-K EchoStar CORP For: Oct 01
-
Form SC 13E3/A Utz Brands, Inc. Filed by: Utz Brands, Inc.
-
Form 4 SCHMID Group N.V. For: Sep 30 Filed by: Rauch Helmut
-
Form 425 Columbus Acquisition Filed by: Columbus Acquisition Corp/Cayman Islands
-
Form 424B1 Chilwa Minerals Ltd
-
Form S-8 Bilibili Inc.
-
Form 8-K Columbus Acquisition For: Oct 01
-
Form 6-K PERUSAHAAN PERSEROAN For: Oct 02
-
Form 6-K Aura Minerals Inc. For: Oct 02
-
Form DEFA14A Quince Therapeutics,
-
Form 8-K/A BNB PLUS CORP. For: Sep 28
-
Form 8-K BNB PLUS CORP. For: Oct 02
-
Form 8-K CERENOME, INC. For: Oct 02
-
Form 8-K Quince Therapeutics, For: Sep 30
-
Form 13F-NT Swedbank Robur Fonder For: Sep 30

